Baroda BNP Paribas Mutual Fund
| Instrument | Industry / rating | Quantity | Value (₹ Cr) | % to NAV |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LimitedSUNPHARMA | Pharmaceuticals & Biotechnology | 2.3 L | 45.7 | 9.01% |
| Divi's Laboratories LimitedDIVISLAB | Pharmaceuticals & Biotechnology | 42,925 | 40.64 | 8.01% |
| Torrent Pharmaceuticals LimitedTORNTPHARM | Pharmaceuticals & Biotechnology | 80,000 | 40.53 | 7.99% |
| IPCA Laboratories LimitedIPCALAB | Pharmaceuticals & Biotechnology | 1.6 L | 31.6 | 6.23% |
| Lupin LimitedLUPIN | Pharmaceuticals & Biotechnology | 1.39 L | 30.42 | 5.99% |
| Laurus Labs LimitedLAURUSLABS | Pharmaceuticals & Biotechnology | 1.5 L | 28.73 | 5.66% |
| Apollo Hospitals Enterprise LimitedAPOLLOHOSP | Healthcare Services | 31,000 | 27.59 | 5.44% |
| Fortis Healthcare LimitedFORTIS | Healthcare Services | 2.52 L | 22.85 | 4.5% |
| AstraZeneca Pharma India LimitedASTRAZEN | Pharmaceuticals & Biotechnology | 26,000 | 18.07 | 3.56% |
| Glenmark Pharmaceuticals LimitedGLENMARK | Pharmaceuticals & Biotechnology | 70,000 | 17.36 | 3.42% |
| Dr. Lal Path Labs LimitedLALPATHLAB | Healthcare Services | 85,000 | 16.44 | 3.24% |
| Mankind Pharma LimitedMANKIND | Pharmaceuticals & Biotechnology | 65,000 | 15.72 | 3.1% |
| Aurobindo Pharma LimitedAUROPHARMA | Pharmaceuticals & Biotechnology | 90,000 | 15.45 | 3.05% |
| Max Financial Services LimitedMFSL | Insurance | 78,498 | 12.35 | 2.43% |
| Emcure Pharmaceuticals LimitedEMCURE | Pharmaceuticals & Biotechnology | 65,110 | 12.08 | 2.38% |
| Abbott India LimitedABBOTINDIA | Pharmaceuticals & Biotechnology | 4,500 | 11.63 | 2.29% |
| Acutaas Chemicals LimitedACUTAAS | Pharmaceuticals & Biotechnology | 36,040 | 11.39 | 2.24% |
| Aster DM Quality Care LimitedASTERDM | Healthcare Services | 1.5 L | 11.34 | 2.23% |
| Zydus Lifesciences LimitedZYDUSLIFE | Pharmaceuticals & Biotechnology | 94,000 | 10.92 | 2.15% |
| Concord Biotech LimitedCONCORDBIO | Pharmaceuticals & Biotechnology | 75,000 | 10.85 | 2.14% |
| Metropolis Healthcare LimitedMETROPOLIS | Healthcare Services | 1.3 L | 7.57 | 1.49% |
| Ajanta Pharma LimitedAJANTPHARM | Pharmaceuticals & Biotechnology | 21,000 | 7.56 | 1.49% |
| Nephrocare Health Services LtdNEPHROPLUS | Healthcare Services | 1 L | 6.83 | 1.35% |
| Manipal Health Enterprises LtdMANIPALHOS | Healthcare Services | 84,750 | 6.46 | 1.27% |
| Symbiotec Pharmalab LimitedSYMBIOTEC | Pharmaceuticals & Biotechnology | 60,720 | 6 | 1.18% |
| Dr. Reddy's Laboratories LimitedDRREDDY | Pharmaceuticals & Biotechnology | 50,000 | 5.77 | 1.14% |
| Gland Pharma LimitedGLAND | Pharmaceuticals & Biotechnology | 20,000 | 5.77 | 1.14% |
| Cipla LimitedCIPLA | Pharmaceuticals & Biotechnology | 40,000 | 5.64 | 1.11% |
| MedPlus Health Services LimitedMEDPLUS | Retailing | 70,000 | 4.71 | 0.93% |
| Inventurus Knowledge Solutions LimitedIKS | IT - Services | 25,000 | 4.34 | 0.85% |
| GlaxoSmithKline Pharmaceuticals LimitedGLAXO | Pharmaceuticals & Biotechnology | 12,000 | 3.66 | 0.72% |
| Procter & Gamble Health LimitedPGHL | Pharmaceuticals & Biotechnology | 5,000 | 2.88 | 0.57% |
| Life Insurance Corporation Of IndiaLICI | Insurance | 57,675 | 2.41 | 0.48% |
| Clearing Corporation of India Ltd | — | — | 5.19 | 1.02% |
| Net Receivables / (Payables) | — | — | 0.97 | 0.2% |
Percentages are the AMC’s own filed figures. Rows without a ticker are instruments outside the listed equity universe — government securities, money-market paper, TREPS and net receivables — and are kept so the portfolio still totals 100%.